Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385438118> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4385438118 endingPage "156" @default.
- W4385438118 startingPage "149" @default.
- W4385438118 abstract "The purpose of this study was to investigate the clinical outcome, inflammatory response and myocardial function in high-risk patients undergoing three different leukocyte depletion strategies. Over a four-month period, forty patients (EuroSCORE 6+) undergoing coronary revascularization were prospectively randomized to one of the four perfusion protocols: Group 1 (N = 10): Conventional circuits (ECC) + two leukocyte filters (LG6B, Pall, USA) with the method of two-phase (continuous + strategic) leukofiltration; Group 2 (N = 10): ECC + single leukocyte filter with the method of continuous leukofiltration; Group 3 (N = 10): ECC + single leukocyte filter with the method of strategic leukofiltration; Group 4 (N = 10) Control: ECC without leukocyte filtration. Blood samples were collected at T1: Baseline, T2: On CPB, T3: X-Clamp, T4: Off CPB, T5: ICU24 and T6: ICU48. Perioperative follow-up was thoroughly monitored. Leukocyte counts in double filter and strategic filtration groups demonstrated significant differences at T4 ( p < .05 vs. control). TNF-alpha levels were significantly lower in Group 1 at T4 and procalcitonin levels at T5 and T6 ( p < .05 vs. control). CKMB levels demonstrated well preserved myocardium in double filter group ( p < .05 vs. control). Brain natriuretic peptide levels in double filter group were significantly lower at T5 and T6 with respect to Group 2 ( p < .05) and control ( p < .001). Matrixmetallopeptidase 9 and D-Dimer levels in double filter group were significantly lower at T5 and T6 ( p < .05 vs. control). Two-phase leukofiltration is associated with some compound benefit over continuous deployment in high-risk patients. A larger more powerful study than this pilot one is warranted for further evaluation." @default.
- W4385438118 created "2023-08-01" @default.
- W4385438118 creator A5009522629 @default.
- W4385438118 creator A5012689412 @default.
- W4385438118 creator A5029414740 @default.
- W4385438118 creator A5039252368 @default.
- W4385438118 creator A5062703921 @default.
- W4385438118 date "2009-09-01" @default.
- W4385438118 modified "2023-09-23" @default.
- W4385438118 title "Clinical Efficacy of Two-Phase Leukocyte Filtration in High-Risk Patients Undergoing Coronary Revascularization with Cardiopul monary Bypass" @default.
- W4385438118 cites W1968615861 @default.
- W4385438118 cites W1971991644 @default.
- W4385438118 cites W1972950515 @default.
- W4385438118 cites W1978760130 @default.
- W4385438118 cites W1982435133 @default.
- W4385438118 cites W1997280199 @default.
- W4385438118 cites W2008181975 @default.
- W4385438118 cites W2024556645 @default.
- W4385438118 cites W2031419081 @default.
- W4385438118 cites W2035790487 @default.
- W4385438118 cites W2036449281 @default.
- W4385438118 cites W2040558851 @default.
- W4385438118 cites W2047619992 @default.
- W4385438118 cites W2089226005 @default.
- W4385438118 cites W2126731653 @default.
- W4385438118 cites W2168311810 @default.
- W4385438118 cites W2172207815 @default.
- W4385438118 cites W4248087073 @default.
- W4385438118 cites W42974555 @default.
- W4385438118 cites W4385437607 @default.
- W4385438118 doi "https://doi.org/10.1051/ject/200941149" @default.
- W4385438118 hasPublicationYear "2009" @default.
- W4385438118 type Work @default.
- W4385438118 citedByCount "0" @default.
- W4385438118 crossrefType "journal-article" @default.
- W4385438118 hasAuthorship W4385438118A5009522629 @default.
- W4385438118 hasAuthorship W4385438118A5012689412 @default.
- W4385438118 hasAuthorship W4385438118A5029414740 @default.
- W4385438118 hasAuthorship W4385438118A5039252368 @default.
- W4385438118 hasAuthorship W4385438118A5062703921 @default.
- W4385438118 hasBestOaLocation W43854381181 @default.
- W4385438118 hasConcept C10936531 @default.
- W4385438118 hasConcept C126322002 @default.
- W4385438118 hasConcept C164705383 @default.
- W4385438118 hasConcept C2778384902 @default.
- W4385438118 hasConcept C2779464278 @default.
- W4385438118 hasConcept C31174226 @default.
- W4385438118 hasConcept C42219234 @default.
- W4385438118 hasConcept C500558357 @default.
- W4385438118 hasConcept C71924100 @default.
- W4385438118 hasConceptScore W4385438118C10936531 @default.
- W4385438118 hasConceptScore W4385438118C126322002 @default.
- W4385438118 hasConceptScore W4385438118C164705383 @default.
- W4385438118 hasConceptScore W4385438118C2778384902 @default.
- W4385438118 hasConceptScore W4385438118C2779464278 @default.
- W4385438118 hasConceptScore W4385438118C31174226 @default.
- W4385438118 hasConceptScore W4385438118C42219234 @default.
- W4385438118 hasConceptScore W4385438118C500558357 @default.
- W4385438118 hasConceptScore W4385438118C71924100 @default.
- W4385438118 hasIssue "3" @default.
- W4385438118 hasLocation W43854381181 @default.
- W4385438118 hasOpenAccess W4385438118 @default.
- W4385438118 hasPrimaryLocation W43854381181 @default.
- W4385438118 hasRelatedWork W2052497673 @default.
- W4385438118 hasRelatedWork W2352247659 @default.
- W4385438118 hasRelatedWork W2354785620 @default.
- W4385438118 hasRelatedWork W2375359181 @default.
- W4385438118 hasRelatedWork W2392422383 @default.
- W4385438118 hasRelatedWork W2586998360 @default.
- W4385438118 hasRelatedWork W2767618185 @default.
- W4385438118 hasRelatedWork W4319770546 @default.
- W4385438118 hasRelatedWork W4324096639 @default.
- W4385438118 hasRelatedWork W3006168697 @default.
- W4385438118 hasVolume "41" @default.
- W4385438118 isParatext "false" @default.
- W4385438118 isRetracted "false" @default.
- W4385438118 workType "article" @default.